Vick C W, Walsh J W, Wheelock J B, Brewer W H
AJR Am J Roentgenol. 1984 Sep;143(3):597-603. doi: 10.2214/ajr.143.3.597.
To evaluate CT criteria for differentiating a cervical cancer confined to the cervix from a lesion that invades the parametria, 16 patients with newly diagnosed, untreated cervical cancer were studied with CT. Twenty-five parametria were confirmed by radical hysterectomy, transvaginal parametrial fine-needle aspiration cytology, or excretory urography. In eight tumor-free parametria, CT findings indicating confined tumor were: (1) smooth, well defined cervical margins; (2) lack of prominent parametrial soft-tissue strands; (3) no parametrial soft-tissue mass; and (4) preservation of the periureteral fat plane. The simultaneous occurrence of these four findings was seen in six of eight tumor-free parametria and in no tumor-infiltrated parametria. In 17 tumor-positive parametria, CT findings associated with parametrial tumor invasion were: (1) irregularity or poor definition of the lateral cervical margins; (2) prominent parametrial soft-tissue strands; (3) obliteration of the periureteral fat plane; and (4) an eccentric parametrial soft-tissue mass. The latter two findings were seen only in tumor-positive parametria. Irregularity of the cervical margins and prominent parametrial strands were seen most commonly with parametrial tumor invasion, but were also occasionally seen with parametrial inflammation. On the basis of the criteria developed in this report, CT may be used as an adjunct to the physical examination in differentiating stage I cervical cancer from more advanced disease in selected patients.
为评估CT鉴别局限于宫颈的宫颈癌与侵犯宫旁组织病变的标准,对16例新诊断、未治疗的宫颈癌患者进行了CT研究。通过根治性子宫切除术、经阴道宫旁细针穿刺细胞学检查或排泄性尿路造影证实了25个宫旁组织的情况。在8个无肿瘤的宫旁组织中,CT显示肿瘤局限的表现为:(1)宫颈边缘光滑、界限清晰;(2)无明显的宫旁软组织条索;(3)无宫旁软组织肿块;(4)输尿管周围脂肪平面存在。这四项表现同时出现见于8个无肿瘤宫旁组织中的6个,而在肿瘤浸润的宫旁组织中均未出现。在17个有肿瘤的宫旁组织中,与宫旁肿瘤侵犯相关的CT表现为:(1)宫颈外侧边缘不规则或界限不清;(2)宫旁软组织条索明显;(3)输尿管周围脂肪平面消失;(4)宫旁软组织肿块偏心。后两项表现仅见于有肿瘤的宫旁组织。宫颈边缘不规则和宫旁条索明显最常见于宫旁肿瘤侵犯,但也偶尔见于宫旁炎症。根据本报告制定的标准,在特定患者中,CT可作为体格检查的辅助手段,用于鉴别I期宫颈癌与更晚期疾病。